These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2050322)

  • 1. Large molecular form of serum HBeAg in chronic hepatitis B virus infection: relation to liver cell damage.
    Kurai K; Iino S; Kurokawa K; Shimoda K; Hino K
    Hepatology; 1991 Jun; 13(6):1057-60. PubMed ID: 2050322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of disease activity in chronic hepatitis B virus infection.
    Yalcin K; Degertekin H; Yildiz F; Celik Y
    Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
    Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
    Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histological characteristics of chronic hepatitis B with negative hepatitis B e-antigen.
    Peng J; Luo K; Zhu Y; Guo Y; Zhang L; Hou J
    Chin Med J (Engl); 2003 Sep; 116(9):1312-7. PubMed ID: 14527355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage.
    Lindh M; Horal P; Dhillon AP; Furuta Y; Norkrans G
    Hepatology; 1996 Sep; 24(3):494-501. PubMed ID: 8781313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
    Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
    Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
    Jelić D; Jelić O
    Acta Med Croatica; 1994; 48(2):77-83. PubMed ID: 7519502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis].
    Li JQ; Zhuang H; Du H; Wang XH; Duan XZ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):491-3. PubMed ID: 16042881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HBV DNA levels, aminotransferase and histological activity in young male patients with HBeAg positive chronic hepatitis B].
    Cho SC; Lee SH; Shinn JJ; Han SH; Roh BJ; Sohn JH; Lee DH; Kee CS
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):44-51. PubMed ID: 12499816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.